TY  - JOUR
AU  - Gonzalez-Mariscal, Isabel
AU  - Pozo-Morales, Macarena
AU  - Romero-Zerbo, Silvana Y
AU  - Espinosa-Jimenez, Vanesa
AU  - Escamilla-Sanchez, Alejandro
AU  - Sanchez-Salido, Lourdes
AU  - Cobo-Vuilleumier, Nadia
AU  - Gauthier, Benoit R
AU  - Bermudez-Silva, Francisco J
PY  - 2021
DO  - 10.1016/j.biopha.2021.112361
UR  - http://hdl.handle.net/10668/22035
T2  - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
AB  - The atypical cannabinoid Abn-CBD improves the inflammatory status in preclinical models of several pathologies, including autoimmune diseases. However, its potential for modulating inflammation in autoimmune type 1 diabetes (T1D) is unknown. Herein we...
LA  - en
PB  - Elsevier
KW  - Beta cell
KW  - Cannabinoids
KW  - Inflammation
KW  - Insulitis
KW  - T cells
KW  - Type 1 diabetes
KW  - Animals
KW  - Apoptosis
KW  - Cytokines
KW  - Diabetes Mellitus, experimental
KW  - Diabetes mellitus, Type 1
KW  - Disease progression
KW  - Female
KW  - Glucose tolerance test
KW  - Inflammation
KW  - Insulin-secreting cells
KW  - Male
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Mice, inbred NOD
KW  - Resorcinols
KW  - Streptozocin
TI  - Abnormal cannabidiol ameliorates inflammation preserving pancreatic beta cells in mouse models of experimental type 1 diabetes and beta cell damage.
TY  - research article
VL  - 145
ER  -